Ability 0 7 0 7 O
to 8 10 8 10 O
undergo 11 18 11 18 O
general 19 26 19 26 B-treatment
or 27 29 27 29 I-treatment
regional 30 38 30 38 I-treatment
spinal 39 45 39 45 I-treatment
or 46 48 46 48 I-treatment
epidural 49 57 49 57 I-treatment
anesthesia 58 68 58 68 I-treatment
as 69 71 69 71 O
per 72 75 72 75 O
standard 76 84 76 84 O
institutional 85 98 85 98 O
practice 99 107 99 107 O

Abnormal 0 8 108 116 O
pulmonary 9 18 117 126 B-treatment
function 19 27 127 135 I-treatment
tests 28 33 136 141 I-treatment
PFT 34 37 142 145 I-treatment

Adequate 0 8 146 154 O
cardiac 9 16 155 162 B-chronic_disease
function 17 25 163 171 I-chronic_disease
, 25 26 171 172 O
defined 27 34 173 180 O
as 35 37 181 183 O
left 38 42 184 188 B-clinical_variable
ventricular 43 54 189 200 I-clinical_variable
ejection 55 63 201 209 I-clinical_variable
fraction 64 72 210 218 I-clinical_variable
greater 73 80 219 226 O
than 81 85 227 231 O
40 86 88 232 234 B-lower_bound
percent 89 96 235 242 I-lower_bound

Adequate 0 8 243 251 O
liver 9 14 252 257 O
function 15 23 258 266 O
as 24 26 267 269 O
defined 27 34 270 277 O
by 35 37 278 280 O
a 38 39 281 282 O
serum 40 45 283 288 B-clinical_variable
conjugated 46 56 289 299 I-clinical_variable
direct 57 63 300 306 I-clinical_variable
bilirubin 64 73 307 316 I-clinical_variable
les 74 77 317 320 O
than 78 82 321 325 O
2.5x 83 87 326 330 B-upper_bound
upper 88 93 331 336 I-upper_bound
limit 94 99 337 342 I-upper_bound
of 100 102 343 345 I-upper_bound
normal 103 109 346 352 I-upper_bound
ULN 110 113 353 356 I-upper_bound
for 114 117 357 360 O
age- 118 122 361 365 B-age
AST 123 126 366 369 B-clinical_variable
and 127 130 370 373 O
ALT 131 134 374 377 B-clinical_variable
less 135 139 378 382 O
than 140 144 383 387 O
5XULN 145 150 388 393 B-upper_bound
for 151 154 394 397 O
age 155 158 398 401 O
as 159 161 402 404 O
per 162 165 405 408 O
local 166 171 409 414 O
laboratory 172 182 415 425 O

Adequate 0 8 426 434 O
renal 9 14 435 440 O
function 15 23 441 449 O
: 23 24 449 450 O
defined 25 32 451 458 O
as 33 35 459 461 O
a 36 37 462 463 O
cystatin 38 46 464 472 B-chronic_disease
C 47 48 473 474 I-chronic_disease
eGFR 49 53 475 479 I-chronic_disease
or 54 56 480 482 O
creatinine 57 67 483 493 B-chronic_disease
clearance 68 77 494 503 I-chronic_disease
eGFR 78 82 504 508 I-chronic_disease
greater 83 90 509 516 O
than 91 95 517 521 O
60ml 96 100 522 526 B-lower_bound
/ 100 101 526 527 I-lower_bound
min/1.73 101 109 527 535 I-lower_bound
sq 110 112 536 538 I-lower_bound
- 112 113 538 539 I-lower_bound
m 113 114 539 540 I-lower_bound

All 0 3 541 544 O
participants 4 16 545 557 O
of 17 19 558 560 O
reproductive 20 32 561 573 O
potential 33 42 574 583 O
must 43 47 584 588 O
agree 48 53 589 594 B-contraception_consent
to 54 56 595 597 I-contraception_consent
a 57 58 598 599 I-contraception_consent
contraceptive 59 72 600 613 I-contraception_consent
method 73 79 614 620 I-contraception_consent
for 80 83 621 624 O
a 84 85 625 626 O
period 86 92 627 633 O
of 93 95 634 636 O
no 96 98 637 639 O
less 99 103 640 644 O
than 104 108 645 649 O
one 109 112 650 653 B-upper_bound
year 113 117 654 658 I-upper_bound
post 118 122 659 663 O
gene 123 127 664 668 B-treatment
transfer 128 136 669 677 I-treatment

Any 0 3 678 681 O
condition 4 13 682 691 O
or 14 16 692 694 O
chronic 17 24 695 702 B-chronic_disease
physical 25 33 703 711 I-chronic_disease
or 34 36 712 714 O
mental 37 43 715 721 B-chronic_disease
illness 44 51 722 729 I-chronic_disease
, 51 52 729 730 O
which 53 58 731 736 O
in 59 61 737 739 O
the 62 65 740 743 O
opinion 66 73 744 751 O
of 74 76 752 754 O
the 77 80 755 758 O
investigator 81 93 759 771 O
makes 94 99 772 777 O
participation 100 113 778 791 O
ill 114 117 792 795 O
advised 118 125 796 803 O

Confirmed 0 9 804 813 O
diagnosis 10 19 814 823 O
of 20 22 824 826 O
sickle 23 29 827 833 B-chronic_disease
cell 30 34 834 838 I-chronic_disease
disease 35 42 839 846 I-chronic_disease
genotype 43 51 847 855 O
Hb- 52 55 856 859 O
S 56 57 860 861 O
/ 57 58 861 862 O
beta 58 62 862 866 O
- 62 63 866 867 O
thalassemia 63 74 867 878 O
or 75 77 879 881 O
Hb 78 80 882 884 O
- 80 81 884 885 O
S/ 81 83 885 887 O
beta 84 88 888 892 O
+ 89 90 893 894 O
thalassemia 91 102 895 906 O
disease 103 110 907 914 O
or 111 113 915 917 O
HbS 114 117 918 921 O
/ 117 118 921 922 O
Hb 118 120 922 924 O
- 120 121 924 925 O
S 121 122 925 926 O
, 122 123 926 927 O
confirmed 124 133 928 937 O
by 134 136 938 940 O
beta 137 141 941 945 O
- 141 142 945 946 O
globin 142 148 946 952 O
gene 149 153 953 957 O
analysis 154 162 958 966 O
and 163 166 967 970 O
a 167 168 971 972 O
hemoglobin 169 179 973 983 O
separation 180 190 984 994 O
method 191 197 995 1001 O

Female 0 6 1002 1008 B-gender
patients 7 15 1009 1017 I-gender
of 16 18 1018 1020 O
childbearing 19 31 1021 1033 O
potential 32 41 1034 1043 O
defined 42 49 1044 1051 O
as 50 52 1052 1054 O
having 53 59 1055 1061 O
achieved 60 68 1062 1070 O
menarche 69 77 1071 1079 O
must 78 82 1080 1084 O
have 83 87 1085 1089 O
a 88 89 1090 1091 O
negative 90 98 1092 1100 B-pregnancy
pregnancy 99 108 1101 1110 I-pregnancy
test 109 113 1111 1115 O
and 114 117 1116 1119 O
not 118 121 1120 1123 O
be 122 124 1124 1126 O
lactating 125 134 1127 1136 O

Frequent 0 8 1137 1145 O
painful 9 16 1146 1153 O
vaso 17 21 1154 1158 B-chronic_disease
- 21 22 1158 1159 I-chronic_disease
occlusive 22 31 1159 1168 I-chronic_disease
episodes 32 40 1169 1177 I-chronic_disease
which 41 46 1178 1183 O
significantly 47 60 1184 1197 O
interfere 61 70 1198 1207 O
with 71 75 1208 1212 O
normal 76 82 1213 1219 O
life 83 87 1220 1224 O
activities 88 98 1225 1235 O
, 98 99 1235 1236 O
defined 100 107 1237 1244 O
as 108 110 1245 1247 O
a 111 112 1248 1249 O
history 113 120 1250 1257 O
of 121 123 1258 1260 O
2 124 125 1261 1262 B-lower_bound
or 126 128 1263 1265 O
more 129 133 1266 1270 O
severe 134 140 1271 1277 O
acute 141 146 1278 1283 O
sickle 147 153 1284 1290 B-chronic_disease
pain 154 158 1291 1295 I-chronic_disease
events 159 165 1296 1302 I-chronic_disease
per 166 169 1303 1306 O
year 170 174 1307 1311 O
requiring 175 184 1312 1321 O
additional 185 195 1322 1332 B-treatment
treatment 196 205 1333 1342 I-treatment
at 206 208 1343 1345 O
a 209 210 1346 1347 O
medical 211 218 1348 1355 O
facility 219 227 1356 1364 O
outside 228 235 1365 1372 O
of 236 238 1373 1375 O
home 239 243 1376 1380 O
pain 244 248 1381 1385 O
management 249 259 1386 1396 O
over 260 264 1397 1401 O
the 265 268 1402 1405 O
preceding 269 278 1406 1415 B-upper_bound
two 279 282 1416 1419 I-upper_bound
year 283 287 1420 1424 I-upper_bound
period 288 294 1425 1431 O
prior 295 300 1432 1437 O
to 301 303 1438 1440 O
study 304 309 1441 1446 O
enrollment 310 320 1447 1457 O
, 320 321 1457 1458 O
or 322 324 1459 1461 O
which 325 330 1462 1467 O
necessitate 331 342 1468 1479 O
chronic 343 350 1480 1487 B-treatment
transfusion 351 362 1488 1499 I-treatment
therapy 363 370 1500 1507 I-treatment

Lansky 0 6 1508 1514 B-clinical_variable
/ 6 7 1514 1515 O
Karnofsky 7 16 1515 1524 B-clinical_variable
performance 17 28 1525 1536 I-clinical_variable
score 29 34 1537 1542 I-clinical_variable
greater 35 42 1543 1550 O
than 43 47 1551 1555 O
or 48 50 1556 1558 O
equal 51 56 1559 1564 O
to 57 59 1565 1567 O
60 60 62 1568 1570 B-lower_bound

Liver 0 5 1571 1576 B-treatment
biopsy 6 12 1577 1583 I-treatment
showing 13 20 1584 1591 O
cirrhosis 21 30 1592 1601 B-chronic_disease
, 30 31 1601 1602 O
bridging 32 40 1603 1611 B-chronic_disease
hepatic 41 48 1612 1619 I-chronic_disease
fibrosis 49 57 1620 1628 I-chronic_disease
, 57 58 1628 1629 O
or 59 61 1630 1632 O
active 62 68 1633 1639 B-chronic_disease
hepatitis 69 78 1640 1649 I-chronic_disease

Minimum 0 7 1650 1657 O
of 8 10 1658 1660 O
two 11 14 1661 1664 O
episodes 15 23 1665 1673 O
of 24 26 1674 1676 O
clinically 27 37 1677 1687 O
diagnosed 38 47 1688 1697 O
acute 48 53 1698 1703 B-chronic_disease
chest 54 59 1704 1709 I-chronic_disease
syndrome 60 68 1710 1718 I-chronic_disease
requiring 69 78 1719 1728 O
hospital 79 87 1729 1737 B-treatment
admission 88 97 1738 1747 I-treatment
, 97 98 1747 1748 O
or 99 101 1749 1751 O
one 102 105 1752 1755 O
life 106 110 1756 1760 O
threatening 111 122 1761 1772 O
episode 123 130 1773 1780 O
of 131 133 1781 1783 O
acute 134 139 1784 1789 O
chest 140 145 1790 1795 O
syndrome 146 154 1796 1804 O
requiring 155 164 1805 1814 O
ICU 165 168 1815 1818 O
admission 169 178 1819 1828 O
for 179 182 1829 1832 O
exchange 183 191 1833 1841 O
transfusion 192 203 1842 1853 O
and 204 207 1854 1857 O
or 208 210 1858 1860 O
intubation 211 221 1861 1871 O
, 221 222 1871 1872 O
or 223 225 1873 1875 O
frequent 226 234 1876 1884 O
acute 235 240 1885 1890 O
chest 241 246 1891 1896 O
syndrome 247 255 1897 1905 O
episodes 256 264 1906 1914 O
, 264 265 1914 1915 O
which 266 271 1916 1921 O
necessitate 272 283 1922 1933 O
treatment 284 293 1934 1943 B-treatment
with 294 298 1944 1948 O
chronic 299 306 1949 1956 B-treatment
transfusion 307 318 1957 1968 I-treatment
therapy 319 326 1969 1976 I-treatment

Moderate 0 8 1977 1985 O
diffusion 9 18 1986 1995 O
defect 19 25 1996 2002 O
is 26 28 2003 2005 O
defined 29 36 2006 2013 O
as 37 39 2014 2016 O
a 40 41 2017 2018 O
DLCO 42 46 2019 2023 O
corrected 47 56 2024 2033 O
for 57 60 2034 2037 O
hemoglobin 61 71 2038 2048 B-clinical_variable
down 72 76 2049 2053 O
to 77 79 2054 2056 O
40 80 82 2057 2059 B-lower_bound
percent 83 90 2060 2067 I-lower_bound
of 91 93 2068 2070 O
predicted 94 103 2071 2080 O

Moderate 0 8 2081 2089 O
obstruction 9 20 2090 2101 O
is 21 23 2102 2104 O
defined 24 31 2105 2112 O
as 32 34 2113 2115 O
per 35 38 2116 2119 O
ATS 39 42 2120 2123 O
criteria 43 51 2124 2132 O
as 52 54 2133 2135 O
a 55 56 2136 2137 O
FEV1 57 61 2138 2142 B-clinical_variable
down 62 66 2143 2147 O
to 67 69 2148 2150 O
60 70 72 2151 2153 B-lower_bound
percent 73 80 2154 2161 I-lower_bound
of 81 83 2162 2164 O
predicted 84 93 2165 2174 O
, 93 94 2174 2175 O
associated 95 105 2176 2186 O
with 106 110 2187 2191 O
a 111 112 2192 2193 O
FEV1 113 117 2194 2198 B-clinical_variable
/ 117 118 2198 2199 I-clinical_variable
FVC 118 121 2199 2202 I-clinical_variable
ratio 122 127 2203 2208 O
below 128 133 2209 2214 O
the 134 137 2215 2218 O
95 138 140 2219 2221 B-upper_bound
percent 141 148 2222 2229 I-upper_bound
confidence 149 159 2230 2240 O
intervals 160 169 2241 2250 O

Moderate 0 8 2251 2259 O
restriction 9 20 2260 2271 O
is 21 23 2272 2274 O
defined 24 31 2275 2282 O
as 32 34 2283 2285 O
a 35 36 2286 2287 O
TLC 37 40 2288 2291 B-clinical_variable
down 41 45 2292 2296 O
to 46 48 2297 2299 O
60 49 51 2300 2302 B-lower_bound
percent 52 59 2303 2310 I-lower_bound
of 60 62 2311 2313 O
predicted 63 72 2314 2323 O

Most 0 4 2324 2328 O
adults 5 11 2329 2335 O
with 12 16 2336 2340 O
sickle 17 23 2341 2347 B-chronic_disease
cell 24 28 2348 2352 I-chronic_disease
disease 29 36 2353 2360 I-chronic_disease
will 37 41 2361 2365 O
have 42 46 2366 2370 O
compromised 47 58 2371 2382 O
PFTs 59 63 2383 2387 O

On 0 2 2388 2390 O
an 3 5 2391 2393 O
investigational 6 21 2394 2409 B-treatment
agent 22 27 2410 2415 I-treatment
in 28 30 2416 2418 O
the 31 34 2419 2422 O
last 35 39 2423 2427 B-upper_bound
30 40 42 2428 2430 I-upper_bound
days 43 47 2431 2435 I-upper_bound

Patients 0 8 2436 2444 O
3 9 10 2445 2446 B-lower_bound
- 10 11 2446 2447 O
35 11 13 2447 2449 B-upper_bound
years 14 19 2450 2455 I-upper_bound
old 20 23 2456 2459 O

Patients 0 8 2460 2468 O
on 9 11 2469 2471 O
chronic 12 19 2472 2479 B-treatment
transfusion 20 31 2480 2491 I-treatment
therapy 32 39 2492 2499 I-treatment
for 40 43 2500 2503 O
severe 44 50 2504 2510 O
disease 51 58 2511 2518 O
symptoms 59 67 2519 2527 O
other 68 73 2528 2533 O
than 74 78 2534 2538 O
those 79 84 2539 2544 O
listed 85 91 2545 2551 O
above 92 97 2552 2557 O
, 97 98 2557 2558 O
and 99 102 2559 2562 O
which 103 108 2563 2568 O
interfere 109 118 2569 2578 O
with 119 123 2579 2583 O
normal 124 130 2584 2590 O
life 131 135 2591 2595 O
activities 136 146 2596 2606 O

Patients 0 8 2607 2615 O
who 9 12 2616 2619 O
are 13 16 2620 2623 O
on 17 19 2624 2626 O
chronic 20 27 2627 2634 B-treatment
transfusions 28 40 2635 2647 I-treatment
for 41 44 2648 2651 O
clinical 45 53 2652 2660 O
stroke 54 60 2661 2667 B-chronic_disease
with 61 65 2668 2672 O
MRA 66 69 2673 2676 B-chronic_disease
cerebral 70 78 2677 2685 I-chronic_disease
vasculopathy 79 91 2686 2698 I-chronic_disease
will 92 96 2699 2703 O
be 97 99 2704 2706 O
excluded 100 108 2707 2715 O
since 109 114 2716 2721 O
patients 115 123 2722 2730 O
in 124 126 2731 2733 O
the 127 130 2734 2737 O
SWITCH 131 137 2738 2744 O
study 138 143 2745 2750 O
who 144 147 2751 2754 O
were 148 152 2755 2759 O
randomized 153 163 2760 2770 O
to 164 166 2771 2773 O
the 167 170 2774 2777 O
hydroxyurea 171 182 2778 2789 O
arm 183 186 2790 2793 O
had 187 190 2794 2797 O
recurrent 191 200 2798 2807 O
stroke 201 207 2808 2814 O
, 207 208 2814 2815 O
while 209 214 2816 2821 O
none 215 219 2822 2826 O
in 220 222 2827 2829 O
the 223 226 2830 2833 O
chronic 227 234 2834 2841 B-treatment
transfusion 235 246 2842 2853 I-treatment
arm 247 250 2854 2857 I-treatment

Patients 0 8 2858 2866 O
who 9 12 2867 2870 O
are 13 16 2871 2874 O
unable 17 23 2875 2881 O
to 24 26 2882 2884 O
take 27 31 2885 2889 O
hydroxyurea 32 43 2890 2901 B-treatment
due 44 47 2902 2905 O
to 48 50 2906 2908 O
financial 51 60 2909 2918 O
or 61 63 2919 2921 O
safety 64 70 2922 2928 O
monitoring 71 81 2929 2939 O
constraints 82 93 2940 2951 O

Patients 0 8 2952 2960 O
who 9 12 2961 2964 O
were 13 17 2965 2969 O
placed 18 24 2970 2976 O
on 25 27 2977 2979 O
chronic 28 35 2980 2987 B-treatment
transfusion 36 47 2988 2999 I-treatment
therapy 48 55 3000 3007 I-treatment
instead 56 63 3008 3015 O
of 64 66 3016 3018 O
hydroxyurea 67 78 3019 3030 B-treatment
for 79 82 3031 3034 O
severe 83 89 3035 3041 O
disease 90 97 3042 3049 B-chronic_disease

Patients 0 8 3050 3058 O
with 9 13 3059 3063 O
alpha 14 19 3064 3069 B-chronic_disease
thalassemia 20 31 3070 3081 I-chronic_disease
two 32 35 3082 3085 O
or 36 38 3086 3088 O
more 39 43 3089 3093 O
gene 44 48 3094 3098 O
deletions 49 58 3099 3108 O
or 59 61 3109 3111 O
any 62 65 3112 3115 O
alpha 66 71 3116 3121 O
- 71 72 3121 3122 O
globin 72 78 3122 3128 O
structural 79 89 3129 3139 O
variants 90 98 3140 3148 O
sickle 99 105 3149 3155 B-chronic_disease
cell 106 110 3156 3160 I-chronic_disease
disease 111 118 3161 3168 I-chronic_disease

Patients 0 8 3169 3177 O
with 9 13 3178 3182 O
an 14 16 3183 3185 O
active 17 23 3186 3192 O
malignant 24 33 3193 3202 B-cancer
disease 34 41 3203 3210 O

Patients 0 8 3211 3219 O
with 9 13 3220 3224 O
evidence 14 22 3225 3233 O
of 23 25 3234 3236 O
uncontrolled 26 38 3237 3249 O
bacterial 39 48 3250 3259 B-chronic_disease
, 48 49 3259 3260 O
viral 50 55 3261 3266 B-chronic_disease
, 55 56 3266 3267 O
or 57 59 3268 3270 O
fungal 60 66 3271 3277 B-chronic_disease
infections 67 77 3278 3288 I-chronic_disease
currently 78 87 3289 3298 O
taking 88 94 3299 3305 O
medication 95 105 3306 3316 B-treatment
and 106 109 3317 3320 O
progression 110 121 3321 3332 O
of 122 124 3333 3335 O
clinical 125 133 3336 3344 O
symptoms 134 142 3345 3353 O
within 143 149 3354 3360 O
one 150 153 3361 3364 B-upper_bound
month 154 159 3365 3370 I-upper_bound
prior 160 165 3371 3376 I-upper_bound
to 166 168 3377 3379 O
starting 169 177 3380 3388 O
the 178 181 3389 3392 O
conditioning 182 194 3393 3405 O
regimen 195 202 3406 3413 O

Patients 0 8 3414 3422 O
with 9 13 3423 3427 O
high 14 18 3428 3432 O
TCD 19 22 3433 3436 B-treatment
do 23 25 3437 3439 O
equally 26 33 3440 3447 O
well 34 38 3448 3452 O
on 39 41 3453 3455 O
chronic 42 49 3456 3463 B-treatment
transfusions 50 62 3464 3476 I-treatment
or 63 65 3477 3479 O
hydroxyurea 66 77 3480 3491 B-treatment
, 77 78 3491 3492 O
as 79 81 3493 3495 O
per 82 85 3496 3499 O
a 86 87 3500 3501 O
subsequent 88 98 3502 3512 O
TWITCH 99 105 3513 3519 O
study 106 111 3520 3525 O
, 111 112 3525 3526 O
where 113 118 3527 3532 O
patients 119 127 3533 3541 O
with 128 132 3542 3546 O
elevated 133 141 3547 3555 B-treatment
TCD 142 145 3556 3559 I-treatment
were 146 150 3560 3564 O
randomized 151 161 3565 3575 O
to 162 164 3576 3578 O
hydroxyurea 165 176 3579 3590 O
or 177 179 3591 3593 O
chronic 180 187 3594 3601 O
transfusions 188 200 3602 3614 O
to 201 203 3615 3617 O
prevent 204 211 3618 3625 O
stroke 212 218 3626 3632 B-chronic_disease

Patients 0 8 3633 3641 O
with 9 13 3642 3646 O
medical 14 21 3647 3654 O
history 22 29 3655 3662 O
of 30 32 3663 3665 O
pulmonary 33 42 3666 3675 B-chronic_disease
hypertension 43 55 3676 3688 I-chronic_disease
, 55 56 3688 3689 O
PHT 57 60 3690 3693 B-chronic_disease
proved 61 67 3694 3700 O
by 68 70 3701 3703 O
cardiac 71 78 3704 3711 B-treatment
catheterization 79 94 3712 3727 I-treatment

Preference 0 10 3728 3738 O
will 11 15 3739 3743 O
be 16 18 3744 3746 O
given 19 24 3747 3752 O
to 25 27 3753 3755 O
Hb 28 30 3756 3758 B-chronic_disease
S/ 31 33 3759 3761 I-chronic_disease
beta- 34 39 3762 3767 I-chronic_disease
thalassemia 40 51 3768 3779 I-chronic_disease
, 51 52 3779 3780 O
followed 53 61 3781 3789 O
by 62 64 3790 3792 O
HbS/ 65 69 3793 3797 B-chronic_disease
beta 70 74 3798 3802 I-chronic_disease
+ 75 76 3803 3804 I-chronic_disease
thalassemia 77 88 3805 3816 I-chronic_disease
, 88 89 3816 3817 O
followed 90 98 3818 3826 O
by 99 101 3827 3829 O
HbS 102 105 3830 3833 O
/ 105 106 3833 3834 O
Hb 106 108 3834 3836 O
- 108 109 3836 3837 O
S 109 110 3837 3838 O

Sero 0 4 3839 3843 O
- 4 5 3843 3844 O
positivity 5 15 3844 3854 O
for 16 19 3855 3858 O
HIV 20 23 3859 3862 B-chronic_disease

Severe 0 6 3863 3869 O
sickle 7 13 3870 3876 B-chronic_disease
cell 14 18 3877 3881 I-chronic_disease
disease 19 26 3882 3889 I-chronic_disease

The 0 3 3890 3893 O
first 4 9 3894 3899 O
six 10 13 3900 3903 O
subjects 14 22 3904 3912 O
, 22 23 3912 3913 O
at 24 26 3914 3916 O
minimum 27 34 3917 3924 O
, 34 35 3924 3925 O
will 36 40 3926 3930 O
be 41 43 3931 3933 O
18 44 46 3934 3936 B-lower_bound
- 46 47 3936 3937 O
35 47 49 3937 3939 B-upper_bound
years 50 55 3940 3945 I-upper_bound
of 56 58 3946 3948 O
age 59 62 3949 3952 B-age
accrual 63 70 3953 3960 O
in 71 73 3961 3963 O
this 74 78 3964 3968 O
age 79 82 3969 3972 O
range 83 88 3973 3978 O
will 89 93 3979 3983 O
continue 94 102 3984 3992 O
until 103 108 3993 3998 O
six 109 112 3999 4002 O
subjects 113 121 4003 4011 O
are 122 125 4012 4015 O
evaluable 126 135 4016 4025 O
and 136 139 4026 4029 O
permission 140 150 4030 4040 O
from 151 155 4041 4045 O
the 156 159 4046 4049 O
IRB 160 163 4050 4053 O
and 164 167 4054 4057 O
FDA 168 171 4058 4061 O
to 172 174 4062 4064 O
enroll 175 181 4065 4071 O
pediatric 182 191 4072 4081 O
patients 192 200 4082 4090 O
has 201 204 4091 4094 O
been 205 209 4095 4099 O
given 210 215 4100 4105 O

Unrelated 0 9 4106 4115 O
donor 10 15 4116 4121 O
HCT 16 19 4122 4125 B-treatment
are 20 23 4126 4129 O
not 24 27 4130 4133 O
performed 28 37 4134 4143 O
as 38 40 4144 4146 O
the 41 44 4147 4150 O
standard 45 53 4151 4159 O
of 54 56 4160 4162 O
care 57 61 4163 4167 O
for 62 65 4168 4171 O
sickle 66 72 4172 4178 B-chronic_disease
cell 73 77 4179 4183 I-chronic_disease
disease 78 85 4184 4191 I-chronic_disease

Women 0 5 4192 4197 B-gender
must 6 10 4198 4202 O
agree 11 16 4203 4208 O
not 17 20 4209 4212 O
to 21 23 4213 4215 O
breast 24 30 4216 4222 O
feed 31 35 4223 4227 O
for 36 39 4228 4231 O
a 40 41 4232 4233 O
period 42 48 4234 4240 O
of 49 51 4241 4243 O
one 52 55 4244 4247 O
year 56 60 4248 4252 O
post 61 65 4253 4257 O
gene 66 70 4258 4262 O
transfer 71 79 4263 4271 O
as 80 82 4272 4274 O
stipulated 83 93 4275 4285 O
in 94 96 4286 4288 O
the 97 100 4289 4292 O
informed 101 109 4293 4301 O
consent 110 117 4302 4309 O
document 118 126 4310 4318 O

adults 0 6 4319 4325 O
and 7 10 4326 4329 O
children 11 19 4330 4338 O
who 20 23 4339 4342 O
do 24 26 4343 4345 O
not 27 30 4346 4349 O
have 31 35 4350 4354 O
matched 36 43 4355 4362 O
sibling 44 51 4363 4370 O
donors 52 58 4371 4377 O
will 59 63 4378 4382 O
be 64 66 4383 4385 O
eligible 67 75 4386 4394 O
for 76 79 4395 4398 O
gene 80 84 4399 4403 O
therapy 85 92 4404 4411 B-treatment
and 93 96 4412 4415 O
no 97 99 4416 4418 O
NMDP 100 104 4419 4423 O
search 105 111 4424 4430 O
for 112 115 4431 4434 O
unrelated 116 125 4435 4444 O
donors 126 132 4445 4451 O
will 133 137 4452 4456 O
be 138 140 4457 4459 O
performed 141 150 4460 4469 O

have 0 4 4470 4474 O
cardiac 5 12 4475 4482 B-treatment
cath 13 17 4483 4487 I-treatment
- 17 18 4487 4488 O
proven 18 24 4488 4494 O
PHT 25 28 4495 4498 O

must 0 4 4499 4503 O
be 5 7 4504 4506 O
off 8 11 4507 4510 O
hydroxyurea 12 23 4511 4522 B-treatment
therapy 24 31 4523 4530 I-treatment
for 32 35 4531 4534 O
3 36 37 4535 4536 B-upper_bound
months 38 44 4537 4543 I-upper_bound
prior 45 50 4544 4549 I-upper_bound
to 51 53 4550 4552 O
stem 54 58 4553 4557 B-treatment
cell 59 63 4558 4562 I-treatment
collection 64 74 4563 4573 I-treatment

patients 0 8 4574 4582 O
who 9 12 4583 4586 O
have 13 17 4587 4591 O
mild 18 22 4592 4596 O
or 23 25 4597 4599 O
moderate 26 34 4600 4608 O
obstruction 35 46 4609 4620 O
or 47 49 4621 4623 O
restriction 50 61 4624 4635 O
or 62 64 4636 4638 O
diffusion 65 74 4639 4648 B-chronic_disease
defects 75 82 4649 4656 I-chronic_disease

patients 0 8 4657 4665 O
with 9 13 4666 4670 O
severe 14 20 4671 4677 O
obstruction 21 32 4678 4689 O
, 32 33 4689 4690 O
restriction 34 45 4691 4702 O
or 46 48 4703 4705 O
diffusion 49 58 4706 4715 B-chronic_disease
defects 59 66 4716 4723 I-chronic_disease

weaning 0 7 4724 4731 O
transfusions 8 20 4732 4744 O
is 21 23 4745 4747 O
necessary 24 33 4748 4757 O
, 33 34 4757 4758 O
so 35 37 4759 4761 O
that 38 42 4762 4766 O
a 43 44 4767 4768 O
selective 45 54 4769 4778 O
pressure 55 63 4779 4787 O
on 64 66 4788 4790 O
gene 67 71 4791 4795 O
- 71 72 4795 4796 O
modified 72 80 4796 4804 O
red 81 84 4805 4808 O
blood 85 90 4809 4814 O
cells 91 96 4815 4820 O
is 97 99 4821 4823 O
evident 100 107 4824 4831 O
, 107 108 4831 4832 O
and 109 112 4833 4836 O
this 113 117 4837 4841 O
will 118 122 4842 4846 O
place 123 128 4847 4852 O
subjects 129 137 4853 4861 O
with 138 142 4862 4866 O
stroke 143 149 4867 4873 B-chronic_disease
risk 150 154 4874 4878 O
at 155 157 4879 4881 O
risk 158 162 4882 4886 O
for 163 166 4887 4890 O
a 167 168 4891 4892 O
recurrent 169 178 4893 4902 O
stroke 179 185 4903 4909 O

